1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Specialties
DarioHealth Corp.

DarioHealth Corp.

DRIO
DarioHealth Corp.US flagNASDAQ Capital Market
7.20
USD
+0.21
- -
52.64MMarket Cap

Total Valuation

DarioHealth Corp. carries a market capitalization of 52.64M, placing it among publicly traded companies globally. Its enterprise value stands at 66.63M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap52.64M
Enterprise Value66.63M

Share Statistics

DarioHealth Corp. currently has 7.30M shares outstanding.

Shares Outstanding7.30M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 2.00, and the price-to-book ratio stands at 0.87.

PE RatioN/A
PS Ratio2.00
PB Ratio0.87
P/TBV Ratio-2.78
P/FCF Ratio-1.66
P/OCF Ratio-1.65

Enterprise Valuation

EV / Sales3.17
EV / EBITDAN/A
EV / EBITN/A
EV / FCFN/A

Financial Position

DarioHealth Corp. maintains a current ratio of 2.31, meaning it holds 2.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 58.84, indicating elevated leverage, while an interest coverage ratio of -6.57 demonstrates limited ability to service its debt obligations.

Current Ratio2.31
Quick Ratio1.89
Debt / Equity58.84
Debt / EBITDA-1.09
Interest Coverage-6.57

Financial Efficiency

Return on Equity (ROE)-76.05
Return on Assets (ROA)-34.81
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover2.11

Taxes

Income Tax468,000.00
Effective Tax RateN/A

Stock Price Statistics

DarioHealth Corp.'s stock has declined approximately -7.45501% over the past 52 weeks. The 50-day moving average sits at 7.17, while the 200-day moving average is 8.71.

Beta (5Y)N/A
52-Week Price Change-7.45501%
50-Day Moving Average7.17
200-Day Moving Average8.71
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, DarioHealth Corp. generated 21.00M in revenue and converted that into -35.67M in net income, yielding earnings per share of -5.61. EBITDA reached -29.71M, while operating income came in at -31.83M.

Revenue21.00M
Gross Profit12.21M
Operating Income-31.83M
Pretax Income-35.20M
Net Income-35.67M
EBITDA-29.71M
EBIT-31.83M
Earnings Per Share (EPS)-5.61

Balance Sheet

DarioHealth Corp. holds 13.96M in cash and equivalents against 32.41M in total debt, resulting in a net debt position of 24.43M. Total book value stands at 55.09M, with working capital of 12.55M providing operational flexibility.

Cash & Cash Equivalents13.96M
Total Debt32.41M
Net Debt24.43M
Equity (Book Value)55.09M
Book Value Per Share7.55
Working Capital12.55M

Cash Flow

DarioHealth Corp. produced -25.34M in operating cash flow over the past twelve months. After subtracting -136,000.00 in capital expenditures, free cash flow totaled -25.48M - equivalent to -4.01 per share.

Operating Cash Flow-25.34M
Capital Expenditures-136,000.00
Free Cash Flow-25.48M
FCF Per Share-4.01

Margins

DarioHealth Corp. operates with a gross margin of 58.15, reflecting its pricing power and cost economics. The operating margin of -151.60 and net profit margin of -169.87 provide insight into operational efficiency.

Gross Margin58.15
Operating Margin-151.60
Pretax Margin-167.64
Profit Margin-169.87
EBITDA Margin-141.51

Dividends & Yields

The company's payout ratio of 21.22 indicates the proportion of earnings distributed to shareholders.

Dividend Per ShareN/A
Dividend YieldN/A
Payout Ratio21.22
Shareholder Yield-36.07
FCF Yield-60.11

Stock Splits

DarioHealth Corp.'s most recent stock split took place on August 28, 2025 with a 20:1 split ratio.

Last Split Date8/28/2025
Split Ratio20:1

Scores

DarioHealth Corp. posts an Altman Z-Score of -29.29, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-29.29